Contrast-induced nephropathy (CIN) is a relatively frequent complication of percutaneous coronary and peripheral artery interventions and is associated with significant in-hospital and long term morbidity and mortality. We aim to compare the impact on major events of RenalGuard system (RG), continuous veno-venous Hemofiltration (CVVH) and hydration (Hy) with sodium bicarbonate plus N-acetylcysteine in patients with severe renal failure.
COMPARISON OF RENALGUARD SYSTEM, CONTINUOUS VENOVENOUS HEMOFILTRATION AND HYDRATION IN HIGH-RISK PATIENTS FOR CONTRAST-INDUCED NEPHROPATHY / Bertelli, L; Politi, L; Roversi, S; Bartolacelli, Y; Perrone, S; Zoccai, Gb; Bursi, F; Sangiorgi, Gm; Modena, Mg. - In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. - ISSN 0735-1097. - 59:13(2012), pp. E96-E96. (Intervento presentato al convegno Congress of American College of Cardiology tenutosi a Chicago, IL nel March 24-27, 2012) [10.1016/s0735-1097(12)60097-7].
COMPARISON OF RENALGUARD SYSTEM, CONTINUOUS VENOVENOUS HEMOFILTRATION AND HYDRATION IN HIGH-RISK PATIENTS FOR CONTRAST-INDUCED NEPHROPATHY
Bertelli, L;Politi, L;Bartolacelli, Y;Modena, MG
2012
Abstract
Contrast-induced nephropathy (CIN) is a relatively frequent complication of percutaneous coronary and peripheral artery interventions and is associated with significant in-hospital and long term morbidity and mortality. We aim to compare the impact on major events of RenalGuard system (RG), continuous veno-venous Hemofiltration (CVVH) and hydration (Hy) with sodium bicarbonate plus N-acetylcysteine in patients with severe renal failure.
| File | Dimensione | Formato | |
|---|---|---|---|
|
82305937.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
105.83 kB
Formato
Adobe PDF
|
105.83 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
